Pliant Therapeutics PLRX Cash Flow Statement (2019-2026)

NASDAQ PLRX
$0.91 +0.01 (+1.52%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Pliant Therapeutics Quarterly Cash Flow Statement

Periods 29 quarters
Latest Jun 2026

Pliant Therapeutics reported cash from operations of -$12.80M and free cash flow of -$12.80M for the quarter ended Jun 2026, up 68.5% year over year. This cash flow statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-27.05M-24.53M-28.10M-29.55M-30.62M-35.06M-37.55M-41.19M-41.49M-41.11M-46.96M-55.85M-57.76M-49.73M-56.17M-43.30M-26.30M-23.58M-20.04M-22.37M
Depreciation and DepletionDep. & Depletion
0.40M0.42M0.50M0.40M0.50M0.42M0.50M0.40M0.50M0.44M0.51M0.60M0.50M0.43M0.45M0.40M0.40M0.37M0.30M0.20M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.40M0.42M0.50M0.40M0.50M0.42M0.50M0.40M0.50M0.44M0.51M0.60M0.50M0.43M0.45M0.40M0.40M0.37M0.30M0.20M
Share-based CompensationStock Comp.
2.81M2.77M3.53M3.40M4.81M10.86M11.92M13.05M10.36M9.15M9.67M10.64M8.90M8.42M8.91M6.38M6.42M4.53M4.25M4.19M
Gains from Sales and DivestituresGains Divest
0.04M0.09M
Gains from Investment SecuritiesGains Investment
-0.01M-0.16M-0.75M-0.31M3.31M-4.01M0.64M-0.92M0.33M2.25M-0.83M-0.13M1.47M-0.53M-0.16M-0.16M0.04M
Other non-cash itemsOther Non-Cash
0.81M-0.11M0.24M0.44M0.58M0.60M0.61M0.63M0.60M0.56M0.68M1.15M0.81M0.81M0.81M0.82M0.82M2.66M0.84M0.84M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.22M0.39M-0.75M3.74M-3.51M0.50M1.31M-1.72M-1.58M
Change in Account PayablesChange Payables
-0.34M0.49M1.77M-1.57M0.05M-1.61M-0.14M0.88M1.06M1.17M2.26M-3.63M3.73M-0.93M-0.34M-4.24M-0.90M0.00M-0.12M1.17M
Change in Accured ExpensesChange Accured Exp.
2.05M1.98M-0.36M5.77M2.91M-0.41M-0.54M5.63M-3.01M0.70M-0.91M5.68M5.17M-6.13M-4.81M-3.81M-2.03M-1.51M-6.47M4.42M
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
0.95M0.92M-1.22M-0.69M-1.14M3.14M0.48M1.33M1.41M0.52M-3.75M3.48M-5.44M1.03M-1.00M-1.01M-0.78M0.21M-2.05M1.14M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.45M-0.84M-0.28M-0.47M-0.62M-0.89M-0.66M-0.68M-0.67M-0.74M-0.36M-0.28M-0.08M-0.09M-0.09M0.13M-0.60M-0.31M-0.32M-0.04M
Other Working Capital ChangesOther WC Changes
-1.40M-1.75M0.95M0.22M0.52M-4.03M-1.13M-2.01M-2.08M-1.26M3.39M-3.76M5.35M-1.12M0.91M1.14M0.18M-0.52M1.73M-1.18M
Cash from OperationsCash from Ops.
-22.51M-19.87M-20.50M-24.40M-18.50M-31.24M-30.28M-24.76M-36.22M-25.10M-30.27M-45.30M-32.27M-47.66M-48.86M-40.60M-21.08M-17.79M-19.23M-12.80M
Investing Activities
Capital ExpendituresCapex
0.48M0.59M0.64M0.25M0.70M0.17M0.16M0.60M0.09M0.06M1.49M1.25M0.90M0.21M0.26M0.11M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.16M0.00M0.10M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.48M-0.59M-0.64M-0.25M-0.70M-0.17M-0.16M-0.60M-0.09M-0.06M-1.49M-1.25M-0.90M-0.21M-0.26M-0.11M0.16M0.00M0.10M0.02M
Purchase of InvestmentsInvestments Purchased
43.14M37.92M39.23M38.82M211.35M36.31M276.62M134.48M114.48M57.50M52.38M48.52M77.03M33.36M14.15M51.61M52.56M85.09M64.90M17.32M
Sale and Maturity of InvestmentsInvestments Sold
75.72M64.30M41.40M45.57M33.80M56.50M102.58M112.10M152.82M89.48M113.41M60.48M108.89M72.70M83.53M87.21M80.33M86.85M60.70M32.79M
Cash from Investing ActivitiesCash from Investing
32.10M25.78M1.53M6.50M-178.25M20.02M-174.21M-22.98M38.25M31.92M59.55M10.70M30.96M39.13M69.11M35.49M27.92M1.77M-4.10M15.49M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-0.15M19.91M0.00M
Non-Current Debt
-0.15M19.91M0.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.15M19.91M0.00M
Change in Capital Stock
Common Stock IssuedStock Issued
0.70M-2.44M216.20M270.25M
Net Shares Issued and RepurchasedNet Shares Issued
0.70M-2.44M216.20M270.25M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.70M-2.44M216.20M270.25M
Other financing activitiesOther financing
-0.25M-0.03M-0.20M-0.02M-0.71M0.38M-0.59M-0.17M-0.08M-0.01M
Cash from Financing ActivitiesCash from Financing
0.45M0.52M-0.15M10.43M216.30M0.28M273.33M0.16M0.70M0.22M21.79M0.68M0.54M0.10M0.50M0.07M-32.27M0.07M
Additional items
Change in Cash
10.04M6.43M-19.12M-7.48M19.55M-10.93M68.84M-47.58M2.73M7.04M51.06M-33.91M-0.77M-8.43M20.75M-5.12M6.91M-48.29M-23.26M2.69M
Ending Cash Balance
45.23M51.67M32.55M25.07M44.62M33.68M102.53M54.95M57.68M64.72M115.78M81.87M81.10M72.67M93.42M88.30M95.21M46.93M23.67M26.37M
Free Cash FlowFCF
-22.99M-20.46M-21.14M-24.65M-19.19M-31.41M-30.44M-25.36M-36.32M-25.16M-31.76M-46.55M-33.17M-47.87M-49.13M-40.72M-21.08M-17.79M-19.23M-12.80M
Net Cash FlowNCF
10.04M6.43M-19.12M-7.48M19.55M-10.93M68.84M-47.58M2.73M7.04M51.06M-33.91M-0.77M-8.43M20.75M-5.12M6.91M-48.29M-23.26M2.69M
Interest Paid
0.07M0.26M0.28M0.28M0.29M0.29M0.29M0.50M0.54M0.81M0.77M0.72M0.73M0.74M0.35M

Pliant Therapeutics Cash Flow Statement API

Pull Pliant Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PLRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY